The respiratory oxygen delivery devices market size has grown rapidly in recent years. It will grow from $16.53 billion in 2025 to $18.26 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to rising prevalence of chronic respiratory diseases, increased hospital admissions for respiratory conditions, expansion of critical care infrastructure, growing aging population with oxygen dependency, wider availability of medical oxygen delivery solutions.
The respiratory oxygen delivery devices market size is expected to see strong growth in the next few years. It will grow to $25.69 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing adoption of remote patient monitoring, rising demand for home healthcare services, growing focus on early respiratory disease management, expansion of smart connected medical devices, increasing investments in respiratory care technologies. Major trends in the forecast period include increasing adoption of high-flow oxygen delivery systems, rising demand for home-based oxygen therapy devices, growing integration of smart oxygen monitoring features, expansion of portable and lightweight oxygen devices, enhanced focus on patient comfort and compliance.
The rising prevalence of asthma is expected to drive the growth of the respiratory oxygen delivery device market moving forward. Asthma is a chronic respiratory condition marked by airway inflammation and constriction, causing recurring episodes of wheezing, coughing, chest tightness, and shortness of breath. The incidence of asthma is increasing due to factors such as air pollution, allergen exposure, genetic predisposition, lifestyle and dietary changes, and urbanization. Respiratory oxygen delivery devices assist in asthma management by providing supplemental oxygen during exacerbations, ensuring sufficient oxygenation, alleviating symptoms, and improving overall respiratory function and quality of life. For instance, in October 2024, according to the National Asthma Council, an Australia-based non-profit organization, there were 474 asthma-related deaths in Australia in 2023, including 325 females and 149 males, nearly matching the 473 deaths reported in 2022. Therefore, the rising prevalence of asthma is driving the respiratory oxygen delivery devices market.
Major companies in the respiratory oxygen delivery device market are focusing on integrating advanced sensor control systems and connectivity features to enhance patient monitoring and therapy effectiveness. These technologies enable devices to automatically adjust performance based on sensor feedback while providing remote access, data sharing, and real-time communication through wireless or network connections. For instance, in October 2024, Inogen, Inc., a US-based medical device company, launched the Rove 4 portable oxygen concentrator, featuring Bluetooth connectivity via the Inogen Connect app. The app allows users to remotely monitor oxygen purity, battery life, and flow settings from their smartphones, illustrating the industry’s move toward connected, high-efficiency PSA-based oxygen devices that support real-time tracking and smarter home therapy.
In February 2023, React Health Inc., a US-based manufacturer and distributor of medical devices for sleep-disordered breathing and oxygen therapy, completed the acquisition of a respiratory product line from Invacare Holdings Corporation for an undisclosed sum. This acquisition broadens React Health's product portfolio to encompass essential respiratory devices, strengthening its foothold in the medical device market, particularly in sleep-disordered breathing and oxygen therapy treatments. Invacare Holdings Corporation is a US-based manufacturing company specializing in respiratory therapy medical equipment, including stationary oxygen concentrators and oxygen refilling devices.
Major companies operating in the respiratory oxygen delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson And Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group, Teleflex Incorporated, Masimo Corporation, Chart Industries Inc., Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hamilton Medical AG, GaleMed Corporation, Weinmann Emergency Medical Technology GmbH And Co. KG, Precision Medical Inc., Allied Healthcare Products Inc., Salter Labs Inc.
Asia-Pacific was the largest region in the respiratory oxygen delivery devices market in 2025. The regions covered in the respiratory oxygen delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the respiratory oxygen delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the respiratory oxygen delivery devices market by increasing costs of imported medical-grade plastics, flow regulators, sensors, valves, and electronic monitoring components used in oxygen masks, cannulas, and concentrators. Hospitals and homecare providers in North America and Europe are most affected due to reliance on globally sourced components, while Asia-Pacific faces cost pressures on device exports. These tariffs are raising device procurement costs and impacting affordability in price-sensitive markets. However, they are also encouraging local manufacturing, regional sourcing of medical components, and investments in cost-optimized oxygen delivery solutions.
The respiratory oxygen delivery devices market research report is one of a series of new reports that provides respiratory oxygen delivery devices market statistics, including respiratory oxygen delivery devices industry global market size, regional shares, competitors with a respiratory oxygen delivery devices market share, detailed respiratory oxygen delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory oxygen delivery devices industry. This respiratory oxygen delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Respiratory oxygen delivery devices are medical tools crafted to administer oxygen to patients requiring supplemental oxygen therapy to support their breathing. They are employed to provide oxygen therapy to individuals with respiratory conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, other lung diseases, as well as those experiencing hypoxemia due to various medical conditions or environmental factors.
The primary product types of respiratory oxygen delivery devices include oxygen masks, nasal cannulas, ventilator masks, non-rebreather masks, bag valve masks, continuous positive airway pressure (CPAP) masks, among others. Oxygen masks are designed to deliver oxygen to patients by covering the nose and mouth, facilitating the inhalation of oxygen-enriched air. These devices are utilized across applications such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, respiratory distress syndrome, pneumonia, among others, and are utilized by end-users including hospitals, outpatient facilities, and home care settings.
The respiratory oxygen delivery devices market consists of sales of nasal cannulas, oxygen masks, oxygen concentrators, and oxygen cylinders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The respiratory oxygen delivery devices market size is expected to see strong growth in the next few years. It will grow to $25.69 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing adoption of remote patient monitoring, rising demand for home healthcare services, growing focus on early respiratory disease management, expansion of smart connected medical devices, increasing investments in respiratory care technologies. Major trends in the forecast period include increasing adoption of high-flow oxygen delivery systems, rising demand for home-based oxygen therapy devices, growing integration of smart oxygen monitoring features, expansion of portable and lightweight oxygen devices, enhanced focus on patient comfort and compliance.
The rising prevalence of asthma is expected to drive the growth of the respiratory oxygen delivery device market moving forward. Asthma is a chronic respiratory condition marked by airway inflammation and constriction, causing recurring episodes of wheezing, coughing, chest tightness, and shortness of breath. The incidence of asthma is increasing due to factors such as air pollution, allergen exposure, genetic predisposition, lifestyle and dietary changes, and urbanization. Respiratory oxygen delivery devices assist in asthma management by providing supplemental oxygen during exacerbations, ensuring sufficient oxygenation, alleviating symptoms, and improving overall respiratory function and quality of life. For instance, in October 2024, according to the National Asthma Council, an Australia-based non-profit organization, there were 474 asthma-related deaths in Australia in 2023, including 325 females and 149 males, nearly matching the 473 deaths reported in 2022. Therefore, the rising prevalence of asthma is driving the respiratory oxygen delivery devices market.
Major companies in the respiratory oxygen delivery device market are focusing on integrating advanced sensor control systems and connectivity features to enhance patient monitoring and therapy effectiveness. These technologies enable devices to automatically adjust performance based on sensor feedback while providing remote access, data sharing, and real-time communication through wireless or network connections. For instance, in October 2024, Inogen, Inc., a US-based medical device company, launched the Rove 4 portable oxygen concentrator, featuring Bluetooth connectivity via the Inogen Connect app. The app allows users to remotely monitor oxygen purity, battery life, and flow settings from their smartphones, illustrating the industry’s move toward connected, high-efficiency PSA-based oxygen devices that support real-time tracking and smarter home therapy.
In February 2023, React Health Inc., a US-based manufacturer and distributor of medical devices for sleep-disordered breathing and oxygen therapy, completed the acquisition of a respiratory product line from Invacare Holdings Corporation for an undisclosed sum. This acquisition broadens React Health's product portfolio to encompass essential respiratory devices, strengthening its foothold in the medical device market, particularly in sleep-disordered breathing and oxygen therapy treatments. Invacare Holdings Corporation is a US-based manufacturing company specializing in respiratory therapy medical equipment, including stationary oxygen concentrators and oxygen refilling devices.
Major companies operating in the respiratory oxygen delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson And Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group, Teleflex Incorporated, Masimo Corporation, Chart Industries Inc., Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hamilton Medical AG, GaleMed Corporation, Weinmann Emergency Medical Technology GmbH And Co. KG, Precision Medical Inc., Allied Healthcare Products Inc., Salter Labs Inc.
Asia-Pacific was the largest region in the respiratory oxygen delivery devices market in 2025. The regions covered in the respiratory oxygen delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the respiratory oxygen delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the respiratory oxygen delivery devices market by increasing costs of imported medical-grade plastics, flow regulators, sensors, valves, and electronic monitoring components used in oxygen masks, cannulas, and concentrators. Hospitals and homecare providers in North America and Europe are most affected due to reliance on globally sourced components, while Asia-Pacific faces cost pressures on device exports. These tariffs are raising device procurement costs and impacting affordability in price-sensitive markets. However, they are also encouraging local manufacturing, regional sourcing of medical components, and investments in cost-optimized oxygen delivery solutions.
The respiratory oxygen delivery devices market research report is one of a series of new reports that provides respiratory oxygen delivery devices market statistics, including respiratory oxygen delivery devices industry global market size, regional shares, competitors with a respiratory oxygen delivery devices market share, detailed respiratory oxygen delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory oxygen delivery devices industry. This respiratory oxygen delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Respiratory oxygen delivery devices are medical tools crafted to administer oxygen to patients requiring supplemental oxygen therapy to support their breathing. They are employed to provide oxygen therapy to individuals with respiratory conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, other lung diseases, as well as those experiencing hypoxemia due to various medical conditions or environmental factors.
The primary product types of respiratory oxygen delivery devices include oxygen masks, nasal cannulas, ventilator masks, non-rebreather masks, bag valve masks, continuous positive airway pressure (CPAP) masks, among others. Oxygen masks are designed to deliver oxygen to patients by covering the nose and mouth, facilitating the inhalation of oxygen-enriched air. These devices are utilized across applications such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, respiratory distress syndrome, pneumonia, among others, and are utilized by end-users including hospitals, outpatient facilities, and home care settings.
The respiratory oxygen delivery devices market consists of sales of nasal cannulas, oxygen masks, oxygen concentrators, and oxygen cylinders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Respiratory Oxygen Delivery Devices Market Characteristics
3. Respiratory Oxygen Delivery Devices Market Supply Chain Analysis
4. Global Respiratory Oxygen Delivery Devices Market Trends and Strategies
5. Respiratory Oxygen Delivery Devices Market Analysis of End Use Industries
7. Global Respiratory Oxygen Delivery Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Respiratory Oxygen Delivery Devices Total Addressable Market (TAM) Analysis for the Market
9. Respiratory Oxygen Delivery Devices Market Segmentation
10. Respiratory Oxygen Delivery Devices Market Regional and Country Analysis
11. Asia-Pacific Respiratory Oxygen Delivery Devices Market
12. China Respiratory Oxygen Delivery Devices Market
13. India Respiratory Oxygen Delivery Devices Market
14. Japan Respiratory Oxygen Delivery Devices Market
15. Australia Respiratory Oxygen Delivery Devices Market
16. Indonesia Respiratory Oxygen Delivery Devices Market
17. South Korea Respiratory Oxygen Delivery Devices Market
18. Taiwan Respiratory Oxygen Delivery Devices Market
19. South East Asia Respiratory Oxygen Delivery Devices Market
20. Western Europe Respiratory Oxygen Delivery Devices Market
21. UK Respiratory Oxygen Delivery Devices Market
22. Germany Respiratory Oxygen Delivery Devices Market
23. France Respiratory Oxygen Delivery Devices Market
24. Italy Respiratory Oxygen Delivery Devices Market
25. Spain Respiratory Oxygen Delivery Devices Market
26. Eastern Europe Respiratory Oxygen Delivery Devices Market
27. Russia Respiratory Oxygen Delivery Devices Market
28. North America Respiratory Oxygen Delivery Devices Market
29. USA Respiratory Oxygen Delivery Devices Market
30. Canada Respiratory Oxygen Delivery Devices Market
31. South America Respiratory Oxygen Delivery Devices Market
32. Brazil Respiratory Oxygen Delivery Devices Market
33. Middle East Respiratory Oxygen Delivery Devices Market
34. Africa Respiratory Oxygen Delivery Devices Market
36. Respiratory Oxygen Delivery Devices Market Competitive Landscape and Company Profiles
37. Respiratory Oxygen Delivery Devices Market Other Major and Innovative Companies
40. Respiratory Oxygen Delivery Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Respiratory Oxygen Delivery Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses respiratory oxygen delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for respiratory oxygen delivery devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The respiratory oxygen delivery devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Oxygen Masks; Nasal Cannula; Venturi Masks; Non-rebreather Masks; Bag Valve Masks; Continuous Positive Airway Pressure (CPAP) Masks; Other Products2) By Application: Chronic Obstructive Pulmonary Disease (COPD); Asthma; Cystic Fibrosis; Respiratory Distress Syndrome; Pneumonia; Other Disease Applications
3) By End-Use: Hospitals; Outpatient Facilities; Home Care
Subsegments:
1) By Oxygen Masks: Simple Oxygen Masks; Partial Rebreather Masks2) By Nasal Cannula: Standard Nasal Cannula; High-Flow Nasal Cannula
3) By Venturi Masks: Fixed Venturi Masks; Adjustable Venturi Masks
4) By Non-Rebreather Masks: Adult Non-Rebreather Masks; Pediatric Non-Rebreather Masks
5) By Bag Valve Masks: Adult Bag Valve Masks; Pediatric Bag Valve Masks
6) By Continuous Positive Airway Pressure (Cpap) Masks: Full-Face Cpap Masks; Nasal Cpap Masks
7) By Other Products: Oxygen Concentrators; Oxygen Cylinders
Companies Mentioned: Medtronic plc; Air Liquide S.A.; Becton Dickinson And Company; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.; Medline Industries Inc.; ResMed Inc.; Drägerwerk AG And Co. KGaA; Smiths Group; Teleflex Incorporated; Masimo Corporation; Chart Industries Inc.; Fisher And Paykel Healthcare Limited; Invacare Corporation; Vyaire Medical Inc.; Inogen Inc.; Drive DeVilbiss Healthcare Inc.; Hamilton Medical AG; GaleMed Corporation; Weinmann Emergency Medical Technology GmbH And Co. KG; Precision Medical Inc.; Allied Healthcare Products Inc.; Salter Labs Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Respiratory Oxygen Delivery Devices market report include:- Medtronic plc
- Air Liquide S.A.
- Becton Dickinson And Company
- Koninklijke Philips N.V.
- GE HealthCare Technologies Inc.
- Medline Industries Inc.
- ResMed Inc.
- Drägerwerk AG And Co. KGaA
- Smiths Group
- Teleflex Incorporated
- Masimo Corporation
- Chart Industries Inc.
- Fisher And Paykel Healthcare Limited
- Invacare Corporation
- Vyaire Medical Inc.
- Inogen Inc.
- Drive DeVilbiss Healthcare Inc.
- Hamilton Medical AG
- GaleMed Corporation
- Weinmann Emergency Medical Technology GmbH And Co. KG
- Precision Medical Inc.
- Allied Healthcare Products Inc.
- Salter Labs Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 18.26 Billion |
| Forecasted Market Value ( USD | $ 25.69 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
